1. ʻIiʻike a me ka mālama ʻana no COVID-19 (Mana hoʻokolohua 8) e ka National Health Commission o ka PRC
ʻOi aku ka makaʻu o ka thromboembolism i nā mea maʻi koʻikoʻi a koʻikoʻi paha, ……, Pono e hoʻohana prophylactically i nā Anticoagulants. I ka thromboembolism, pono e hoʻokō ʻia ka lāʻau anticoagulant e like me nā kuhikuhi e pili ana.

2.-Pili ka maʻi CELL SARS-CoV-2 i ka Cellular Heparan Sulfate a me ACE2, Heparin a me nā mea loaʻa ʻole anticoagulant i kāpae i ka hoʻopaʻa ʻana o SARSCoV-2 a me ka maʻi.

3. ʻO ka lapaʻau wale nō e hoʻohana ākea ʻia ma kēia wahi ʻo ka pale pale o ka heparin haʻahaʻa molekoki haʻahaʻa (LMWH), kahi e pono ai e noʻonoʻo ʻia i nā mea maʻi āpau me ka pneumonia coronary (me nā mea maʻi ʻole koʻikoʻi) me ka ʻole o nā contraindications
ʻO ke alakaʻi kūwa ʻole ISTH ma ka ʻike a me ka hoʻokele ʻana o coagulopathy ma COVID-19

4. I nā mea maʻi (nā mākua a me nā ʻōpio) haukapila me COVID-19, e hoʻohana i ka prophlaxis lāʻau, e like me ka heparin haʻahaʻa mole mole (e like me ka enoxaparin), e like me nā kūlana kūloko a kūwaho hoʻi, e pale aku ai i ka thromboembolism venous, ke ʻole cont conticated.

5. ʻO nā mea maʻi āpau me ka COVID-19 koʻikoʻi a koʻikoʻi, haʻahaʻa a kaulike paha i ka liʻiliʻi o ke kahe ʻana o ke kahe, a ʻaʻohe koi ʻia e hoʻohana i nā lāʻau e pale aku ai iā VTE, a ʻo ka heparin kaumaha molaki haʻahaʻa ke koho mua. no ka lawa pono o ka hakuʻala, paipai ʻia heparin unfractionated.
No nā mea maʻi ʻoluʻolu a maʻamau hoʻi, inā nui a kūpikipiki paha ka hopena o VTE, paipai ʻia ka pale ʻana i ka lāʻau ma hope o ka hoʻopau ʻia ʻana o nā contraindications, a ʻo ka heparin molekope haʻahaʻa ka koho mua loa.

Kāohi a me ka mālama ʻana i ka Venombo Thromboembolism i hui pū ʻia me ka maʻi Coronavirus 2019 maʻi: He ʻōlelo kūkākūkā ma mua o nā alakaʻi.